Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Exercise of Options

20th Apr 2011 14:59

RNS Number : 2038F
Allergy Therapeutics PLC
20 April 2011
 



20 April 2011

 

Allergy Therapeutics plc

("Allergy Therapeutics" or "the Company")

 

Exercise of Options

 

 

Allergy Therapeutics plc (AIM: AGY), the fully integrated speciality pharmaceutical company specialising in allergy vaccines, announces it has made an application to the London Stock Exchange for 15,000 ordinary shares of 0.1p each to be admitted to trading on AIM. Dealing is expected to commence in these shares on 21 April 2011. The ordinary shares have been allotted pursuant to the exercise of options and will rank pari passu in all respects with the existing ordinary share capital of the Company. The total number of shares in issue (inclusive of the above issue) is 310,771,614 ordinary shares of 0.1p each.

 

 

 

For further information

 

Allergy Therapeutics

+44 (0) 1903 845 820

Manuel Llobet, Chief Executive Officer

Ian Postlethwaite, Finance Director

www.allergytherapeutics.com

Nomura Code Securities

+44 (0) 207 776 1200

Juliet Thompson/ Clare Terlouw

Financial Dynamics

+44 (0) 207 831 3113

Ben Brewerton/ Susan Quigley

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
LISEALLNFSNFEFF

Related Shares:

Allergy Thera.
FTSE 100 Latest
Value8,599.48
Change56.92